CR Bard Inc. announced July 25 the close of enrollment in its LEVANT 2
U.S. pivotal trial comparing its Moxy paclitaxel-coated percutaneous transluminal angioplasty balloon with standard balloon angioplasty for peripheral artery disease. Bard...
Research In Brief
Trial updates on a drug-coated balloon, a lung cancer genomics assay and deep transcranial magnetic brain stimulation for autism, among clinical data news.
More from Clinical Trials
More from R&D
• By
J&J's EMEA head of digital solutions, Julia Fishman, talks about the major hurdles in scaling digital innovation, tips for clinical adoption and what’s up next on J&J’s innovation road map. Robot-assisted surgery pioneer Ivo Broeders gives his perspective on the difficulties in clinical adoption.
• By
The KINCISE 2 Surgical Automated System aims to “reduce the physical burden on surgeons compared to manual impaction in primary and revision hip and revision knee replacement procedures,” said J&J MedTech.
• By
Allen Burton, Abbott’s medical director of neuromodulation told Medtech Insight that the delivery system was developed to make the procedure easier for physicians, especially those who perform the implantations infrequently.